CA2188599A1 - Compositions pharmaceutiques a base de derives de la classe des taxanes - Google Patents

Compositions pharmaceutiques a base de derives de la classe des taxanes

Info

Publication number
CA2188599A1
CA2188599A1 CA002188599A CA2188599A CA2188599A1 CA 2188599 A1 CA2188599 A1 CA 2188599A1 CA 002188599 A CA002188599 A CA 002188599A CA 2188599 A CA2188599 A CA 2188599A CA 2188599 A1 CA2188599 A1 CA 2188599A1
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
docetaxel
based pharmaceutical
derivative based
taxane class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002188599A
Other languages
English (en)
Other versions
CA2188599C (fr
Inventor
Manfred Durr
Jorg-Christian Hager
Armin Wendel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9404951A external-priority patent/FR2718963B1/fr
Application filed by Individual filed Critical Individual
Publication of CA2188599A1 publication Critical patent/CA2188599A1/fr
Application granted granted Critical
Publication of CA2188599C publication Critical patent/CA2188599C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)

Abstract

Composition pharmaceutique stable et fortement concentrée en principe actif de la classe des taxoïdes comme le docétaxel ou les dérivés du docétaxel, caractérisée en ce qu'elle comprend un agent thérapeutique de la classe des taxoïdes comme le docétaxel ou les dérivés du docétaxel, un ou plusieurs phospholipides insaturés et une faible quantité d'un ou plusieurs phospholipides négatifs.
CA002188599A 1994-04-25 1995-04-24 Compositions pharmaceutiques a base de derives de la classe des taxanes Expired - Fee Related CA2188599C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9404951A FR2718963B1 (fr) 1994-04-25 1994-04-25 Nouvelle composition pharmaceutique à base de taxoïdes.
FR94/04951 1994-04-25
PCT/FR1995/000532 WO1995028923A1 (fr) 1994-04-25 1995-04-24 Compositions pharmaceutiques a base de derives de la classe des taxanes

Publications (2)

Publication Number Publication Date
CA2188599A1 true CA2188599A1 (fr) 1995-11-02
CA2188599C CA2188599C (fr) 2006-10-31

Family

ID=37395776

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002188599A Expired - Fee Related CA2188599C (fr) 1994-04-25 1995-04-24 Compositions pharmaceutiques a base de derives de la classe des taxanes

Country Status (1)

Country Link
CA (1) CA2188599C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114588272A (zh) * 2022-04-08 2022-06-07 皖西学院 一种负载no的多西紫杉醇纳米药物及其制备方法和应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114588272A (zh) * 2022-04-08 2022-06-07 皖西学院 一种负载no的多西紫杉醇纳米药物及其制备方法和应用
CN114588272B (zh) * 2022-04-08 2023-05-26 皖西学院 一种负载no的多西紫杉醇纳米药物及其制备方法和应用

Also Published As

Publication number Publication date
CA2188599C (fr) 2006-10-31

Similar Documents

Publication Publication Date Title
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
TR200003478T2 (tr) Antikanser maddeleri olarak faydalı izotiyazol türevleri
AU2412695A (en) Taxane class derivative based pharmaceutical compositions
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
TR200101335T2 (tr) İktidarsızlık tedavisi için pirazolopirimidinon türevleri
EP0738152A4 (fr) Agents de chimioprevention ou de chimiotherapie du cancer du colon a base de derives de l'acide 2-hydroxy-5-phenylazobenzoique
BR0209709A (pt) Composições hipotensivas de lipìdio e timolol e métodos de uso das mesmas
EA200000718A1 (ru) Композиции целекоксиба
EA200100872A1 (ru) Композиция валдекоксиба
MA24694A1 (fr) Derives de thienopyrimidine et thienopyridine utiles comme agents anticancereux, et compositions les contenant.
PT902789E (pt) Derivados de androsteno
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
EP1315506A4 (fr) Derives phospholipides de l'acide valproique et leurs melanges
MY120318A (en) Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
TR199700858A2 (xx) Alzheimer hastal���n�n tedavisine y�nelik ispen�iyari bile�imler.
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
CA2188599A1 (fr) Compositions pharmaceutiques a base de derives de la classe des taxanes
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
FR2732604B1 (fr) Derives et conjugues du mdp presentant une activite stimulatrice de la fonction hematopoietique et compositions les contenant
MX9604984A (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
KR970032876A (ko) 간장질환 치료용 의약 조성물
KR950023403A (ko) 치은증식 억제제 조성물

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150424